Laboratory Proficiency Testing Market in terms of revenue was estimated to be worth $1.2 billion in 2023 and is poised to reach $1.6 billion by 2028, growing at a CAGR of 7.4% from 2023 to 2028 according to a new report by MarketsandMarkets™.
The growth of the laboratory proficiency market is primarily driven by stringent safety and quality regulations for food and pharmaceutical products, increasing focus on water testing, and increasing number of laboratory accreditations. However, the need for proficiency testing scheme harmonization and the dearth of skilled professionals pose potential challenges to the market landscape. The growth of the pharmaceutical proficiency testing market is driven by the growth of the pharmaceuticals market, the surge in the generics market, stringent quality control in the production of pharmaceutical products, and the emerging biosimilars market, while the major restraining factor is cost and time-intensive drug manufacturing process.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144227949
Clinical Diagnostics to account for the largest share of the market during the forecast period.
Based on industry, the laboratory proficiency testing market is segmented into clinical diagnostics, microbiology, pharmaceuticals, food & animal feed, water, biologics, environmental, commercial beverages, cosmetics, cannabis/opioids, dietary supplements, and nutraceuticals. In 2022, the clinical diagnostics segment accounted for the largest share of the laboratory proficiency testing market. Factors such as the rising demand for early and accurate disease diagnosis, advancements in clinical diagnostic techniques, rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures, increasing incidence of target diseases, and growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, are driving the growth of the clinical diagnostics segment.
Chromatography segment is expected to grow at the highest rate during the forecast period.
Based on technology, the global proficiency testing market is segmented by various technologies, including chromatography, spectrophotometry, immunoassays, PCR, cell culture, and other techniques. In 2022, the cell culture segment held the largest market share in the Laboratory Proficiency Testing market. However, it is anticipated that the chromatography segment will experience the highest compound annual growth rate (CAGR) during the forecast period. This can be attributed to the increasing use of chromatographic techniques in water, pharmaceutical, and food industries.
The APAC Laboratory Proficiency Testing market is projected to grow at the highest rate during the forecast period.
The laboratory proficiency testing market is segmented into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the largest market share. However, it’s expected that the Asia Pacific (APAC) market will experience the most rapid growth throughout the forecast period. This growth is mainly attributed to the rising demand for outsourcing analytical testing services in countries such as China, India, Japan, and Singapore. In addition, governments and regulatory bodies across APAC countries are tightening regulations to ensure the accuracy and reliability of testing and measurements. These factors are supporting the growth of the adoption of laboratory proficiency tests in the region.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144227949
Laboratory Proficiency Testing Market Dynamics:
- Stringent safety and quality regulations for food and pharmaceutical products
- Requirement of high-capital investments for accurate and sensitive testing
- Growth opportunities in emerging countries
- Logistical and data interpretation challenges
Key Market Players:
The prominent players in the laboratory proficiency testing market are LGC Limited (UK), College of American Pathologists (US), Bio-Rad Laboratories (US), Merck KGaA (Germany), American Proficiency Institute (US), Randox Laboratories (UK), Fapas (Fera Science Ltd.) (UK), Waters Corporation (US), QACS (Greece), Weqas (UK), AOAC INTERNATIONAL (US), Bipea (France), SPEX CertiPrep (US), Absolute Standards Inc. (US), Trilogy Analytical Laboratory (US), Advanced Analytical Solutions (US), American Industrial Hygiene Association (US), Matrix Sciences (US), Aashvi Proficiency Testing & Analytical Services (India), Global Proficiency (New Zealand), The Emerald Test (US), FLUXANA GmbH & Co. KG (Germany), Phenova Inc. (US), FARE Labs (India), Go Plus Services SDN BHD (Malaysia), and Muva Kempten GmbH (Germany).
- In July 2023, LGC Limited (US) acquired Kavo International (US) to strengthen its portfolio of quality measurement tools.
- In March 2023, the College of American Pathologists (US)launched a new proficiency testing program focused on the monkeypox (mpox) virus. By introducing the new mpox PT program, laboratories can enhance the quality assurance of their molecular testing process and contribute to the assurance of precise and dependent test outcomes, aiding in the detection of the mpox virus.
- In April 2022, Spex CertiPrep (US) acquired NSI Lab Solutions (US) to strengthen its product portfolio in the proficiency testing segment.
- In January 2022, Fera Science Ltd. – FAPAS (UK) formed a partnership with BioFront Technologies, which will act as the agent representing FAPAS proficiency testing services in the United States.
- In October 2021, Waters Corporation (US) entered into a partnership with Sartorius AG (Germany). The objective of this collaboration was to offer bioprocess experts direct access to top-notch mass spectrometry (MS) data, thereby enhancing the efficiency and precision of biopharmaceutical process development.
- Also in October 2021, Waters Corporation (US) partnered with the University of Delaware (US) to develop new analytical solutions for bioprocessing and biomanufacturing.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=144227949
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Address:630 Dundee Road Suite 430
State: IL 60062
Country: United States